Compare Bio Protocol (BIO) vs Neuron (NRN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio Protocol vs Neuron — how do they compare? Bio Protocol trades at Rp441.39 (market cap Rp1T, Rp164,61M 24h volume), while Neuron trades at Rp63.99 (market cap Rp26,48M, Rp841,43jt 24h volume). The key difference: Bio Protocol is far larger — about 37764.4× Neuron's market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 358,6M / 1B NRN (36%) for Neuron. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and Neuron for 11 Days on average.
| BIO | NRN | |
|---|---|---|
Market Cap | Rp1T | Rp26,48M |
Volume (24h) | Rp164,61M | Rp841,43jt |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 358,6M / 1B NRN (36%) |
Typical Hold Time | 18 Days | 11 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
Neuron (NRN) presents a unique case with a very low market cap of Rp26.48M and a circulating supply of 358.6jt tokens (36% of max supply), indicating a nascent stage. The average hold time of 11 days suggests active, short-term trading. Without a current price, technical analysis is limited, but the asset's micro-cap status implies high volatility and liquidity risk. No recent protocol updates or ecosystem news were identified, pointing to low current development activity.
Overall outlook is highly speculative due to the token's small size and lack of recent developments. The primary opportunity lies in potential future ecosystem growth from its early stage. Major risks include extreme price volatility, low liquidity making entry/exit difficult, and the high chance of price manipulation. Investors should approach with caution and only allocate risk capital.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →About Neuron
NRN is developing an ecosystem aimed at accelerating the journey toward Artificial General Intelligence (AGI), using Gaming and robotics as experimental platforms. At its core is NRN Agents, a platform that facilitates the integration of AI agents within advanced Gaming experiences in both virtual and physical environments. The technology stack combines data aggregation, model training, and model inspection, utilizing both imitation learning and reinforcement learning to advance AI development.
Read more on NRN →
